EWL-20737-38623
2 vaccinations
1 coded response
6 check-ins
1 free-text entry
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 226 / VA
- Registered
- 2022-11-02
- Relationship
- Child or adolescent in my care
- Guardian
- M89-29709-89153
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-19
Dose 1 — Moderna
-
2022-11-02
Registered in v-safe
-
2022-11-02
Dose 2 — ModernaCo-administered: Flu
- 2022-11-02
- 2022-11-04
- 2022-11-05
-
2022-11-16
Survey response — day 14, dose 2, under 3MedDRA: Malaise — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Flu/Covid like illnessMedDRA releases: 2024-11 · check-in free text available
-
2022-11-16
Report sent to call center — day 14, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-23
- 2023-02-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-19 | Moderna | No |
| 2 | 2022-11-02 | Moderna | Flu |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Flu/Covid like illness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malaise | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release